HNST vs KMB: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: KMB is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. HNST and KMB share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined HNST and KMB exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

The Honest Company, Inc. is a consumer-products company founded on a clean, plant-based, transparency-focused philosophy. Its core business is baby and personal care: diapers, baby wipes, and a range of personal-care and skin-care items, alongside the Honest Beauty line and some household and wellness products. Honest sells through a mix of large retail partners (including Target, Amazon, and Walmart) and its own direct channels, positioning itself as a trusted, ingredient-conscious brand for parents and shoppers who want non-toxic formulations. The company was co-founded by Jessica Alba and went public in 2021.

Full HNST guide

Kimberly-Clark is a consumer staples company that makes and sells personal care and tissue products under household brand names. Its portfolio includes Huggies diapers, Pull-Ups training pants, Kotex feminine care, Depend and Poise adult incontinence products, Kleenex tissues, Cottonelle and Scott bath tissue, and Viva paper towels. The company organizes around three segments: Personal Care (its largest and most profitable), Consumer Tissue, and a professional/away-from-home business serving offices, restaurants, and institutions (sold under the Kimberly-Clark Professional banner). Roughly half of revenue comes from outside North America, with meaningful exposure to developing and emerging markets where category penetration is still rising. Kimberly-Clark makes money by selling repeat-purchase, non-discretionary household essentials at scale, leaning on brand strength, retail distribution, and manufacturing efficiency. The business is a classic defensive staple: steady demand, modest organic growth, and a long dividend history. Headquartered in Irving, Texas, it has been a Dividend Aristocrat for decades.

Full KMB guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• HNST drivers: Margin-led turnaround; Brand strength in clean categories.
• KMB drivers: Defensive, repeat-purchase demand; Emerging-market category growth.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The biggest risk is that Honest operates in a small, crowded, and price-competitive category where much larger rivals have deeper marketing budgets and shelf power. For KMB, kimberly-Clark sells largely commoditized products where private-label store brands compete aggressively on price, capping pricing power and pressuring volumes when consumers trade down.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick HNST if you believe its drivers more; KMB if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the HNST and KMB guides.

HNST. Figures are approximate, tied to the asOf date, and should be verified against the latest filings before acting. Because Honest is only around breakeven, traditional earnings multiples are not very meaningful yet; investors tend to watch organic revenue growth, adjusted gross margin, and the path to consistent profitability more than a P/E ratio. As a small-cap consumer brand mid-turnaround, the stock can move sharply on quarterly results and guidance changes.

KMB. Kimberly-Clark trades at a defensive-staples multiple, lower than faster-growing consumer names but supported by a high, durable dividend yield. The valuation reflects slow organic growth offset by predictable cash flow and decades of dividend increases. It tends to be valued like a bond proxy, with the multiple sensitive to interest rates and the dividend yield as the primary anchor for income investors.

Headline figures (approximate, Jul 2026): HNST shows revenue (fy2026 guidance) ~$306 million to $312 million (full-year company guidance; Q1 2026 was ~$78 million, down ~20% year over year on exited lines), organic revenue trend Up low single digits year over year (excluding apparel, fulfillment, and Canada exits), adjusted gross margin Record level in the low-to-mid 40s percent range (Q1 2026), profitability Around breakeven net result with modest adjusted net income in recent quarters; KMB shows revenue (ttm) ~$20 billion, operating margin ~16%, net income (ttm) ~$2.5 billion, p/e (ttm) ~18x.

HNST and KMB are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined HNST and KMB exposure against your real portfolio. It is not an investment adviser.